Sanofi's Lemtrada Improves Disability Scores in MS Patients - Bloomberg

[**Sanofi's Lemtrada Improves **Disability** Scores in MS Patients**][1]
**Bloomberg**
Sanofi (SAN), France's largest drugmaker, said its experimental medicine Lemtrada led to an improvement in **disability** scores in patients with multiple sclerosis compared to an older treatment. Lemtrada, also known as alemtuzumab, slowed the progression **...**

[**and more »**][2]

[1]: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFPMOGGqLcbyIcfieLqbmsYoYcU9w&url=http://www.bloomberg.com/news/2012-04-24/sanofi-s-lemtrada-improves-disability-scores-in-ms-patients.html
[2]: http://news.google.com/news/more?gl=us&pz=1&ned=us&ncl=ddM7PlYI-ZAtd7M

URL: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFPMOGGqLcbyIcfieLqbmsYoYcU9w&url=http://www.bloomberg.com/news/2012-04-24/sanofi-s-lemtrada-improves-disability-scores-in-ms-patients.html